Bioage Labs Analyst Price Targets - Benzinga

Bioage Labs Inc

BIOANASDAQ

Trade with Public

Trade with Public

$9.59

0.090.95%

À la clôture: Sep 4, 5:00 PM EST

$9.55

-0.04-0.42%

Après les heures: Sep 4, 6:14 PM EST

Aperçu Actualités Prévisions de résultats ÉvénementsObjectifs de coursDonnées financières Sentiment Actionnariat Comparer Options Rapport sur les stocks

Bioage Labs Analyst Price Targets

Wall Street analyst price targets and consensus rating for Bioage Labs (BIOA).

Price Target Range — 6 Quarters

Analyst Consensus — 8 Analysts

7Buy

1Hold

Consensus RatingBuy# Analysts8Avg. Consensus PT$46Upside to Avg. PT+384.3%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 6, 2026	BTIG	Thomas Shrader	Maintained	Buy	$40
Aug 3, 2026	BTIG	Thomas Shrader	Maintained	Buy	$40
Jul 31, 2026	Needham	Joseph Stringer	PT Cut	Buy	$50→$35
May 27, 2026	Roth Capital	Adam Walsh	Initiate	Buy	$36
May 13, 2026	BTIG	Thomas Shrader	Initiate	Buy	$40
Mar 27, 2026	Needham	Joseph Stringer	Initiate	Buy	$50
Mar 10, 2026	Citigroup	Samantha Semenkow	PT Raise	Buy	$15→$52
Feb 25, 2026	Oppenheimer	Jay Olson	Initiate	Outperform	$60
Feb 18, 2026	Jefferies	Roger Song	Upgrade	Hold→Buy	$9→$62
Jan 27, 2026	Piper Sandler	Yasmeen Rahimi	Initiate	Overweight	$73
Dec 8, 2025	Morgan Stanley	Jeffrey Hung	Upgrade	Underweight→Equal-Weight	$5→$12
Oct 29, 2025	Citigroup	Samantha Semenkow	PT Raise	Buy	$10→$15
Oct 22, 2025	Citigroup	Samantha Semenkow	Upgrade	Neutral→Buy	$5→$10
Mar 24, 2025	Citigroup	Samantha Semenkow	PT Cut	Neutral	$7→$5
Mar 7, 2025	Morgan Stanley	Jeffrey Hung	Assumes	Underweight	$5
Feb 28, 2025	William Blair	Andy Hsieh	Initiate	Market Perform	—
Dec 9, 2024	Citigroup	Samantha Semenkow	Downgrade	Buy→Neutral	$45→$7
Dec 9, 2024	Jefferies	Roger Song	Downgrade	Buy→Hold	$42→$7
Oct 21, 2024	Citigroup	Samantha Semenkow	Initiate	Buy	$45
Oct 21, 2024	Morgan Stanley	Jeffrey Hung	Initiate	Overweight	$40

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
BTIG Reiterates Buy on Bioage Labs, Maintains $40 Price Target

BTIG analyst Thomas Shrader reiterates Bioage Labs (NASDAQ:BIOA) with a Buy and maintains $40 price target.

Benzinga Newsdesk

PRO
BTIG Reiterates Buy on Bioage Labs, Maintains $40 Price Target

BTIG analyst Thomas Shrader reiterates Bioage Labs (NASDAQ:BIOA) with a Buy and maintains $40 price target.

Benzinga Newsdesk

PRO
Needham Maintains Buy on Bioage Labs, Lowers Price Target to $35

Needham analyst Joseph Stringer maintains Bioage Labs (NASDAQ:BIOA) with a Buy and lowers the price target from $50 to $35.

Benzinga Newsdesk

Why Is BioAge Labs Stock Sinking Friday?

BioAge Labs stock plummeted as failed Phase 3 ZEUS trial data from Novo Nordisk sparked broad concerns for NLRP3-targeting therapies.

Vandana Singh

This GE Aerospace Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Top Wall Street analysts changed outlook on top names. See analyst ratings page for upgrades, downgrades, and initiations. Check out what analysts think of GE stock.

Avi Kapoor

PRO
Roth Capital Initiates Coverage On Bioage Labs with Buy Rating, Announces Price Target of $36

Roth Capital analyst Adam Walsh initiates coverage on Bioage Labs (NASDAQ:BIOA) with a Buy rating and announces Price Target of $36.

Benzinga Newsdesk